PURPOSE: To evaluate the effect of intraoperative use of mitomycin-C (MMC) on the corneal
endothelium during excimer laser photorefractive keratectomy (PRK). SETTING: Vanak Eye …

PURPOSE: To evaluate the efficacy and safety of photorefractive keratectomy (PRK) with
intraoperative application of mitomycin-C (MMC). SETTING: Yonsei Eye Center, Seoul …

ABSTRACT PURPOSE: To evaluate the efficacy, safety, and predictability of therapeutic
scraping and application of a diluted 0.02% mitomycin C solution to treat haze and …

Purpose: To identify preoperative and intraoperative factors affecting breakthrough corneal
haze incidence after photorefractive keratectomy (PRK) with mitomycin C (MMC). Methods …

Purpose To evaluate the anti‐haze effect and visual outcome after intraoperative mitomycin
C (MMC) use during photorefractive keratectomy (PRK) in myopia or myopic astigmatism …

Comparison of Standard (0.02%) and Low Dose (0.002%) Mitomycin C in the Prevention of
Corneal Haze Following Surface Ablation fo Page 1 journalofrefractivesurgery.com S68 …

PURPOSE: To retrospectively assess risk factors other than high myopia for corneal haze in
patients who had conventional photorefractive keratectomy (PRK) without mitomycin-C …

Purpose To compare differences in the endothelial cells before and after photorefractive
keratectomy (PRK) for myopia with refractive error graded mitomycin C (MMC) application …

Purpose. To study the long term refractive and visual outcomes of photorefractive
keratectomy (PRK) with intraoperative application of mitomycin C (MMC). Methods. This …

Purpose: To evaluate the epithelial healing following photorefractive keratectomy (PRK) with
mitomycin C (MMC) 0.02%. Methods: A total of 1520 eyes of 760 patients with myopia with …